NCT01700920View on ClinicalTrials.gov

PHASE II CLINICAL TRIAL Prospective, Open, Nonrandomized Treatment of Osteonecrosis of the Femoral Head by the Administration of Autologous Mesenchymal Stem Cells

PHASE2CompletedINTERVENTIONAL
Enrollment

3

Participants

Timeline

Start Date

July 31, 2012

Primary Completion Date

December 31, 2015

Study Completion Date

December 31, 2015

Conditions
Osteonecrosis of the Femoral Head
Interventions
PROCEDURE

bone marrow aspirate

Trial Locations (1)

37007

University Hospital of Salamanca, Salamanca

All Listed Sponsors
collaborator

Haematology Service,University Hospital of Salamanca, MªConsuelo del Cañizo Fernández-Roldán

OTHER

collaborator

Spanish National Health System

OTHER

lead

Red de Terapia Celular

INDUSTRY

NCT01700920 - PHASE II CLINICAL TRIAL Prospective, Open, Nonrandomized Treatment of Osteonecrosis of the Femoral Head by the Administration of Autologous Mesenchymal Stem Cells | Biotech Hunter | Biotech Hunter